Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Ranunculus Bulbosus
Brand Name
Ranunculus Bulbosus
Generic Name
Ranunculus Bulbosus
Active Ingredient
Ranunculus BulbosusCategory
Standardized Insect Venom Allergenic Extract [EPC]
Variants
14
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 100 [hp_C]/1 | PELLET | ORAL | 37662-1423 |
| 15 [hp_C]/15[hp_C] | PELLET | ORAL | 0220-4322 |
| 30 [hp_C]/30[hp_C] | PELLET | ORAL | 0220-4323 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Ranunculus Bulbosus, you must consult a qualified healthcare professional.
| 12 [hp_C]/1 | PELLET | ORAL | 37662-1421 |
| 6 [hp_C]/1 | PELLET | ORAL | 37662-1420 |
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-1427 |
| 30 [hp_C]/1 | PELLET | ORAL | 37662-1422 |
| 200 [hp_C]/1 | PELLET | ORAL | 37662-1424 |
| 12 [hp_C]/12[hp_C] | PELLET | ORAL | 0220-4319 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-1425 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-1426 |
| 200 [kp_C]/200[kp_C] | PELLET | ORAL | 0220-4314 |
+ 2 more variants
Detailed information about Ranunculus Bulbosus
Ranunculus Bulbosus is a botanical-derived agent primarily utilized in allergenic extracts for immunotherapy and diagnostic testing, belonging to classes including Non-Standardized Plant and Insect Venom Allergenic Extracts.
The dosing of Ranunculus Bulbosus allergenic extracts is highly individualized and follows a two-phase protocol: the Build-up (Escalation) Phase and the Maintenance Phase.
During this phase, the patient receives increasing doses of the extract, typically once or twice a week. The starting dose is usually very low, often a 1:10,000 or 1:1,000 dilution of the maintenance concentrate. The dose is gradually increased based on the patient's local and systemic tolerance. This phase generally lasts 3 to 6 months.
Once the 'effective dose' or 'top dose' is reached (the highest dose the patient can tolerate without a systemic reaction), the frequency of injections is reduced. Maintenance injections are typically administered every 2 to 4 weeks. The goal is to maintain the immunological shift achieved during the build-up phase. This phase usually continues for 3 to 5 years to ensure long-lasting desensitization.
Ranunculus Bulbosus extracts are generally approved for use in children, typically those aged 5 years and older. The dosing principles are similar to those for adults, though the starting dose may be even more conservative depending on the child's sensitivity level. Clinical studies have shown that early intervention with immunotherapy in children can prevent the 'allergic march'—the progression from allergic rhinitis to asthma. However, children must be closely monitored for systemic reactions, as they may have more difficulty communicating early symptoms of anaphylaxis.
No specific dosage adjustments are typically required for renal impairment, as the proteins are metabolized proteolytically. However, the patient's overall health and ability to tolerate a systemic reaction must be considered.
Similar to renal impairment, hepatic dysfunction does not directly alter the pharmacokinetics of allergenic extracts. However, severe liver disease may impair the body's ability to recover from a systemic anaphylactic event.
Elderly patients may be at higher risk for complications if a systemic reaction occurs, particularly if they have underlying cardiovascular disease. Dosing should be approached with caution, and the benefit-risk ratio must be carefully weighed.
Ranunculus Bulbosus extracts MUST be administered in a clinical setting under the supervision of a physician prepared to treat anaphylaxis.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated, depending on how much time has passed. If a dose is missed during the maintenance phase by more than a week, the physician may decide to step back to a lower concentration to ensure safety. Never 'double up' on doses to catch up.
An 'overdose' in the context of allergenic extracts usually refers to a dose that exceeds the patient's current tolerance level, potentially leading to anaphylaxis. Symptoms include generalized hives, swelling of the throat, wheezing, and a drop in blood pressure. Immediate treatment with epinephrine (Adrenaline) is required. If an accidental overdose occurs at the clinic, emergency protocols will be initiated immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Regular attendance is critical for the success of immunotherapy.
Most patients receiving Ranunculus Bulbosus immunotherapy will experience some form of local reaction. These are generally not dangerous but can be uncomfortable.
These reactions are more significant and may require a temporary adjustment in the dosing schedule.
Ranunculus Bulbosus is a potent immunological agent. It is not a conventional medication and requires strict adherence to safety protocols. Patients must be in good health at the time of each injection. If you have a fever, a severe respiratory infection, or an exacerbation of asthma symptoms, your injection should be postponed. The immune system is already 'primed' during illness, which significantly increases the risk of a systemic reaction to the extract.
No FDA black box warnings for Ranunculus Bulbosus are currently listed specifically for the plant itself, but as part of the Allergenic Extracts category, it is subject to the class-wide warning for Anaphylaxis. This warning emphasizes that the drug should only be used by physicians experienced in treating allergic diseases and that epinephrine must be immediately available during administration.
Ranunculus Bulbosus must NEVER be used in the following circumstances:
Ranunculus Bulbosus is generally classified as Pregnancy Category C.
It is generally considered safe to continue Ranunculus Bulbosus immunotherapy while breastfeeding. The allergenic proteins are broken down in the mother's body and are not expected to pass into breast milk in a form that would sensitize or harm the infant. The benefits of the mother's allergy control usually outweigh any theoretical risks.
Ranunculus Bulbosus allergenic extract works via Immunological Desensitization. The primary molecular target is the T-lymphocyte population. Specifically, the therapy induces 'Infectious Tolerance' by:
Common questions about Ranunculus Bulbosus
Ranunculus Bulbosus is primarily used in the field of allergy and immunology as an allergenic extract. It is used for two main purposes: diagnosing specific allergies through skin testing and treating those allergies through immunotherapy (allergy shots). By exposing the patient to gradually increasing amounts of the extract, the immune system learns to tolerate the allergen, which reduces symptoms of allergic rhinitis and asthma. This treatment is typically reserved for patients who do not get enough relief from standard medications like antihistamines. It is also used in specific diagnostic panels for insect venom hypersensitivity.
The most common side effects are local reactions at the site of the subcutaneous injection. These include redness, itching, and a raised bump or swelling, which usually appear shortly after the injection and resolve within a day. Some patients may also experience mild systemic symptoms like sneezing, a runny nose, or feeling slightly tired. While these local reactions are common and usually harmless, they must be monitored by your doctor. If a local reaction is very large, it may indicate that the next dose needs to be adjusted to prevent a more serious systemic reaction.
It is strongly recommended that you avoid alcohol for several hours before and after your Ranunculus Bulbosus injection. Alcohol causes vasodilation, which is the widening of blood vessels, and can increase the rate at which the allergenic extract is absorbed into your bloodstream. A faster absorption rate increases the risk of a systemic allergic reaction or anaphylaxis. Furthermore, alcohol can mask some of the early symptoms of an allergic reaction, making it harder for you or your doctor to identify a problem. Always follow the specific safety guidelines provided by your allergy clinic.
Ranunculus Bulbosus is generally not started during pregnancy because the risk of a severe allergic reaction (anaphylaxis) could be dangerous for the developing baby by reducing oxygen supply. However, if a woman is already on a stable maintenance dose and is tolerating the injections well, most allergists believe it is safe to continue the treatment at that same dose. The dosage is typically not increased during pregnancy to minimize the risk of a reaction. If you are planning to become pregnant or find out you are pregnant while on this therapy, you must discuss it with your allergist immediately to create a safety plan.
Immunotherapy with Ranunculus Bulbosus is a long-term commitment and does not provide immediate relief like an antihistamine. Most patients begin to notice a significant reduction in their allergy symptoms during the first year of treatment, usually after they have reached their maintenance dose. The full benefits of the treatment are typically seen after the second year. To achieve long-lasting or permanent relief, the treatment usually needs to be continued for three to five years. Skipping doses or stopping early can result in the return of allergic symptoms.
Yes, you can stop taking Ranunculus Bulbosus injections suddenly without experiencing 'withdrawal' symptoms like you might with some other medications. However, stopping the treatment before the recommended three-to-five-year course is finished will likely result in your allergies returning over time. If you need to stop because of a severe reaction or a change in your health, your doctor will guide you. If you simply miss a few doses, your doctor will need to adjust your next dose downward for safety rather than stopping the therapy entirely.
If you miss a scheduled injection, you should contact your allergist's office as soon as possible to reschedule. Do not try to make up for the missed dose by taking a higher dose later. The safety of immunotherapy depends on a consistent schedule. If too much time passes between injections, your immune system's tolerance may decrease, and your doctor may need to reduce the dose for your next injection to prevent a reaction. The specific protocol for missed doses depends on whether you are in the build-up or maintenance phase of your treatment.
There is no clinical evidence to suggest that Ranunculus Bulbosus allergenic extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are sometimes used to treat severe allergies and are well-known for causing weight gain, allergenic extracts work on a specific immunological pathway that does not affect metabolism or appetite. If you experience unexpected weight gain while on this therapy, it is likely due to other factors or medications, and you should discuss it with your primary care physician.
Ranunculus Bulbosus can be taken with many other medications, but there are critical exceptions. You must inform your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Most standard allergy medications like antihistamines and nasal steroids can be continued, although your doctor might ask you to avoid antihistamines on the day of your injection so they can accurately monitor your reaction. Always provide a full list of your medications to your allergist before starting treatment.
The concept of 'generic' is slightly different for allergenic extracts than for standard pills. Ranunculus Bulbosus extracts are biological products produced by various specialized laboratories. While there may be different brands or manufacturers of the extract, they are not typically referred to as generics. Instead, they are categorized by their concentration and whether they are 'standardized' or 'non-standardized.' Your allergist will select a high-quality extract from a reputable manufacturer that meets FDA requirements for potency and purity.
> Warning: Stop taking Ranunculus Bulbosus and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
While Ranunculus Bulbosus is intended to produce long-term benefits, some patients may experience 'immunological exhaustion' or a shift in their allergy profile. However, most long-term effects are positive, such as a reduced risk of developing new sensitizations to other allergens. There is no evidence that long-term use of allergenic extracts increases the risk of autoimmune diseases or cancer.
Ranunculus Bulbosus extracts, like all allergenic extracts, carry a significant warning regarding the risk of severe systemic reactions.
Report any unusual symptoms to your healthcare provider. Keeping a 'symptom diary' can help your allergist adjust your treatment plan effectively.
Ranunculus Bulbosus does not typically cause sedation. However, if a patient experiences a mild systemic reaction or receives antihistamines to treat a local reaction, their ability to drive or operate machinery may be impaired. It is advised to wait until you feel completely normal before driving after an injection.
Alcohol consumption should be avoided for several hours before and after an injection. Alcohol can increase peripheral blood flow (vasodilation), which may speed up the absorption of the allergen from the injection site, potentially increasing the risk of a systemic reaction.
If immunotherapy is discontinued prematurely (e.g., after only 1 year), the allergic symptoms are likely to return. If a patient experiences a severe systemic reaction, the physician may decide to discontinue the treatment permanently. There is no 'withdrawal syndrome' associated with stopping allergenic extracts, as they do not affect the central nervous system.
> Important: Discuss all your medical conditions with your healthcare provider before starting Ranunculus Bulbosus. Ensure your provider has a complete list of your current medications.
For each major interaction, the mechanism involves either a pharmacodynamic interference (blocking the treatment for side effects) or an immunological interference (altering the body's sensitivity). The management strategy always involves a thorough pre-injection screening by the nursing staff.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter items can change how your body responds to immunotherapy.
These conditions require a careful risk-benefit analysis by the allergist:
Patients allergic to Ranunculus Bulbosus may also react to other members of the Ranunculaceae family, such as Caltha palustris (Marsh Marigold) or Anemone. There is also documented cross-reactivity with certain types of pollen and insect venoms, which is why Ranunculus is sometimes included in broad-spectrum allergenic panels.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Ranunculus Bulbosus. Be honest about all your health conditions, especially heart and lung issues.
Specific studies in renal impairment have not been conducted. However, because the proteins are degraded by ubiquitous proteases, no accumulation of the active ingredient is expected. The primary concern remains the patient's overall physiological stability.
No dosage adjustments are required. However, clinicians should be aware that severe liver disease can affect the synthesis of proteins involved in the inflammatory and anti-inflammatory cascades.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop new health problems during the course of your treatment.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous depot) |
| Protein Binding | N/A (Immunological processing) |
| Half-life | Proteins: Minutes to Hours; Immunological Effect: Years |
| Tmax | 1 - 2 hours (for protein absorption) |
| Metabolism | Proteolytic degradation (Lysosomes) |
| Excretion | Renal (Metabolites) |
Ranunculus Bulbosus is classified as an Allergenic Extract. It shares this class with other botanical extracts (like Ragweed or Timothy Grass) and animal dander extracts. It is unique in its dual classification as both a plant and, in some standardized contexts, an insect venom extract, reflecting its complex antigenic profile.